BMY vs CAG · P/E 17, rev $24.46B vs P/E 31, rev $11.28B
Bristol-Myers Squibb Company (BMY) versus ConAgra Foods Inc (CAG) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
ConAgra Foods Inc (CAG) is a packaged foods company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported CAG revenue for 2026-05-31 was $11.28B. Net income was -$1.92B. Revenue was down 2.9% from 2025-05-25 to 2026-05-31. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
Not investment advice. Open the BMY and CAG stock pages for the full models.
Not investment advice.